BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21734042)

  • 1. Inhibition of HIV-1 integration in ex vivo-infected CD4 T cells from elite controllers.
    Buzon MJ; Seiss K; Weiss R; Brass AL; Rosenberg ES; Pereyra F; Yu XG; Lichterfeld M
    J Virol; 2011 Sep; 85(18):9646-50. PubMed ID: 21734042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infrequent recovery of HIV from but robust exogenous infection of activated CD4(+) T cells in HIV elite controllers.
    Julg B; Pereyra F; Buzón MJ; Piechocka-Trocha A; Clark MJ; Baker BM; Lian J; Miura T; Martinez-Picado J; Addo MM; Walker BD
    Clin Infect Dis; 2010 Jul; 51(2):233-8. PubMed ID: 20550452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+ T cells from elite controllers resist HIV-1 infection by selective upregulation of p21.
    Chen H; Li C; Huang J; Cung T; Seiss K; Beamon J; Carrington MF; Porter LC; Burke PS; Yang Y; Ryan BJ; Liu R; Weiss RH; Pereyra F; Cress WD; Brass AL; Rosenberg ES; Walker BD; Yu XG; Lichterfeld M
    J Clin Invest; 2011 Apr; 121(4):1549-60. PubMed ID: 21403397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of host restriction factors in HIV-1 elite controllers.
    Abdel-Mohsen M; Raposo RA; Deng X; Li M; Liegler T; Sinclair E; Salama MS; Ghanem Hel-D; Hoh R; Wong JK; David M; Nixon DF; Deeks SG; Pillai SK
    Retrovirology; 2013 Oct; 10():106. PubMed ID: 24131498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional profiling of CD4 T cells identifies distinct subgroups of HIV-1 elite controllers.
    Vigneault F; Woods M; Buzon MJ; Li C; Pereyra F; Crosby SD; Rychert J; Church G; Martinez-Picado J; Rosenberg ES; Telenti A; Yu XG; Lichterfeld M
    J Virol; 2011 Mar; 85(6):3015-9. PubMed ID: 21177805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Levels of Macrophage Inflammatory Proteins Result in Resistance to R5-Tropic HIV-1 in a Subset of Elite Controllers.
    Walker WE; Kurscheid S; Joshi S; Lopez CA; Goh G; Choi M; Barakat L; Francis J; Fisher A; Kozal M; Zapata H; Shaw A; Lifton R; Sutton RE; Fikrig E
    J Virol; 2015 May; 89(10):5502-14. PubMed ID: 25740989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4 T-cell regeneration in HIV-1 elite controllers.
    Yang Y; Al-Mozaini M; Buzon MJ; Beamon J; Ferrando-Martinez S; Ruiz-Mateos E; Rosenberg ES; Pereyra F; Yu XG; Lichterfeld M
    AIDS; 2012 Mar; 26(6):701-6. PubMed ID: 22301416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How do HIV elite controllers do what they do?
    Saag M; Deeks SG
    Clin Infect Dis; 2010 Jul; 51(2):239-41. PubMed ID: 20550453
    [No Abstract]   [Full Text] [Related]  

  • 9. Unstimulated primary CD4+ T cells from HIV-1-positive elite suppressors are fully susceptible to HIV-1 entry and productive infection.
    Rabi SA; O'Connell KA; Nikolaeva D; Bailey JR; Jilek BL; Shen L; Page KR; Siliciano RF; Blankson JN
    J Virol; 2011 Jan; 85(2):979-86. PubMed ID: 21068257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-B*57 elite suppressor and chronic progressor HIV-1 isolates replicate vigorously and cause CD4+ T cell depletion in humanized BLT mice.
    Salgado M; Swanson MD; Pohlmeyer CW; Buckheit RW; Wu J; Archin NM; Williams TM; Margolis DM; Siliciano RF; Garcia JV; Blankson JN
    J Virol; 2014 Mar; 88(6):3340-52. PubMed ID: 24390323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blimp-1 overexpression is associated with low HIV-1 reservoir and transcription levels in central memory CD4+ T cells from elite controllers.
    de Masson A; Kirilovsky A; Zoorob R; Avettand-Fenoel V; Morin V; Oudin A; Descours B; Rouzioux C; Autran B
    AIDS; 2014 Jul; 28(11):1567-77. PubMed ID: 24804861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral reservoirs in elite controllers of HIV-1 infection: Implications for HIV cure strategies.
    Woldemeskel BA; Kwaa AK; Blankson JN
    EBioMedicine; 2020 Dec; 62():103118. PubMed ID: 33181459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nef Proteins from HIV-1 Elite Controllers Are Inefficient at Preventing Antibody-Dependent Cellular Cytotoxicity.
    Alsahafi N; Ding S; Richard J; Markle T; Brassard N; Walker B; Lewis GK; Kaufmann DE; Brockman MA; Finzi A
    J Virol; 2015 Dec; 90(6):2993-3002. PubMed ID: 26719277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.
    Van Gulck E; Bracke L; Heyndrickx L; Coppens S; Atkinson D; Merlin C; Pasternak A; Florence E; Vanham G
    PLoS One; 2012; 7(5):e37792. PubMed ID: 22666392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines Elevated in HIV Elite Controllers Reduce HIV Replication
    Jacobs ES; Keating SM; Abdel-Mohsen M; Gibb SL; Heitman JW; Inglis HC; Martin JN; Zhang J; Kaidarova Z; Deng X; Wu S; Anastos K; Crystal H; Villacres MC; Young M; Greenblatt RM; Landay AL; Gange SJ; Deeks SG; Golub ET; Pillai SK; Norris PJ
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: mechanisms of HIV elite control in two African women.
    Moosa Y; Tanko RF; Ramsuran V; Singh R; Madzivhandila M; Yende-Zuma N; Abrahams MR; Selhorst P; Gounder K; Moore PL; Williamson C; Abdool Karim SS; Garrett NJ; Burgers WA
    BMC Infect Dis; 2018 Jan; 18(1):54. PubMed ID: 29370775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved central memory and activated effector memory CD4+ T-cell subsets in human immunodeficiency virus controllers: an ANRS EP36 study.
    Potter SJ; Lacabaratz C; Lambotte O; Perez-Patrigeon S; Vingert B; Sinet M; Colle JH; Urrutia A; Scott-Algara D; Boufassa F; Delfraissy JF; Thèze J; Venet A; Chakrabarti LA
    J Virol; 2007 Dec; 81(24):13904-15. PubMed ID: 17928341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.
    Ferrando-Martínez S; Casazza JP; Leal M; Machmach K; Muñoz-Fernández MÁ; Viciana P; Koup RA; Ruiz-Mateos E
    J Virol; 2012 Apr; 86(7):3667-74. PubMed ID: 22278254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune activation and antibody responses in non-progressing elite controller individuals infected with HIV-1.
    Bello G; Velasco-de-Castro CA; Bongertz V; Rodrigues CA; Giacoia-Gripp CB; Pilotto JH; Grinsztejn B; Veloso VG; Morgado MG
    J Med Virol; 2009 Oct; 81(10):1681-90. PubMed ID: 19697415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of plasmacytoid dendritic cell and CD4+ T cell in HIV elite controllers.
    Herbeuval JP; Smith N; Thèze J
    Clin Dev Immunol; 2012; 2012():869505. PubMed ID: 23243424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.